Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial

Articolo
Data di Pubblicazione:
2022
Citazione:
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial / Gouëffic, Yann; Torsello, Giovanni; Zeller, Thomas; Esposito, Giovanni; Vermassen, Frank; Hausegger, Klaus Armin; Tepe, Gunnar; Thieme, Marcus; Gschwandtner, Michael; Kahlberg, Andrea; Schindewolf, Marc; Sapoval, Marc; Diaz-Cartelle, Juan; Stavroulakis, Konstantinos. - In: CIRCULATION. - ISSN 0009-7322. - 146:21(2022), pp. 1564-1576. [10.1161/CIRCULATIONAHA.122.059606]
Abstract:
A clear patency benefit of a drug-eluting stent (DES) over bare metal stents (BMSs) for treating peripheral artery disease of the femoropopliteal segment has not been definitively demonstrated. The EMINENT study (Trial Comparing Eluvia Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery) was designed to evaluate the patency of the Eluvia DES (Boston Scientific, Marlborough, MA), a polymer-coated paclitaxel-eluting stent, compared with BMSs for the treatment of femoropopliteal artery lesions.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
drug-eluting stents; endovascular procedures; paclitaxel; peripheral arterial disease; Humans; Prospective Studies; Quality of Life; Vascular Patency; Popliteal Artery; Femoral Artery; Stents; Paclitaxel; Polymers; Treatment Outcome; Drug-Eluting Stents; Peripheral Arterial Disease
Elenco autori:
Autori di Ateneo:
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/133951
Link al Full Text:
Pubblicato in:
CIRCULATION
Journal